CROFT-LEOMINSTER INC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 3.64 and the average weighting 0.7%.

Quarter-by-quarter ownership
CROFT-LEOMINSTER INC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$241,000
-35.7%
10,000
-48.7%
0.06%
-36.0%
Q1 2017$375,000
+68.2%
19,500
+34.5%
0.09%
+71.2%
Q4 2016$223,000
+18.6%
14,5000.0%0.05%
+10.6%
Q3 2016$188,00014,5000.05%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$16,279,0002.44%
Abingworth LLP 1,041,131$6,517,0002.23%
Telemetry Investments, L.L.C. 194,789$1,219,0002.06%
AIGH Capital Management LLC 749,608$4,692,0001.91%
Trellus Management Company, LLC 340,000$2,128,0001.76%
Bruce & Co., Inc. 929,312$5,817,0001.12%
Worth Venture Partners, LLC 191,093$1,196,0000.95%
GENERAL AMERICAN INVESTORS CO INC 1,000,751$6,265,0000.62%
Weil Company, Inc. 104,907$657,0000.39%
NEXPOINT ASSET MANAGEMENT, L.P. 140,020$877,0000.29%
View complete list of PARATEK PHARMACEUTICALS INC shareholders